Ching‐Hsuan Tung

Also affiliated with Molecular Innovations (United States), Weill Cornell Medicine

EngineeringBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy”.

Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy

Cancers(2020)10.3390/cancers12040780

N/A

0DataRank · unranked

27 citations

Ching‐Hsuan Tung, Youli Zu, Zihua Zeng

RHAMMB-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.10.002

N/A

0DataRank · unranked

13 citations

Seung Koo Lee, Mei Song, Tiantian Zhang, Myung Shin Han, Yao‐Tseng Chen +5 more

RHAMM B -mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.28.432124

N/A

0DataRank · unranked

0 citations

Seung‐Koo Lee, Mei Song, Tiantian Zhang, Myung Shin Han, Yao‐Tseng Chen +5 more